The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Obesity and peritoneal surface disease: Outcomes following cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC).
Konstantinos I Votanopoulos
No relevant relationships to disclose
Katrina R Swett
No relevant relationships to disclose
Doug S Swords
No relevant relationships to disclose
Perry Shen
No relevant relationships to disclose
John Stewart
No relevant relationships to disclose
Edward A. Levine
No relevant relationships to disclose